Disease Course and Patient’s Characteristics in a Regional First Level Hospital in Western-Germany During the First Three Covid-19 Surges from March 2020 to July 2021

Goller Julia, Ratayczak Mark, Dahlem Markus, B. M., Ballmann Clemens, Middeldorf Thomas, Lengfeld Hendrik, Ess Gabriele, Bill Oliver, Tekin G, Schmitz Volker
{"title":"Disease Course and Patient’s Characteristics in a Regional First Level Hospital in Western-Germany During the First Three Covid-19 Surges from March 2020 to July 2021","authors":"Goller Julia, Ratayczak Mark, Dahlem Markus, B. M., Ballmann Clemens, Middeldorf Thomas, Lengfeld Hendrik, Ess Gabriele, Bill Oliver, Tekin G, Schmitz Volker","doi":"10.26420/thrombhaemostres.2022.1076","DOIUrl":null,"url":null,"abstract":"The worldwide spread of SARS-CoV-2 profoundly affected almost all aspects of public life and challenged international and national health institutions of all different medical care levels including Europe up from the very beginning in 2020 until today. Public and press perception might have been weighed somehow towards third level health care providers offering treatment options like ECMO therapy for Covid-19 patients with the worst disease course, the majority of patients who needed hospital care were treated in hospitals of the first level. These hospitals provided about 50% of intensive care treatments in the federal state of Rhineland Palatinate (RLP) in Germany, too [1]. According to the Destatis [2] about 71000 additional deaths were registered in Germany during the first 12 months (02/2020 – 02/2021) of pandemic of which about 50000 could be attributed to Covid-19 as given in the medical death reports. However, only few data has been published on the concrete disease course and patient´s outcome on the scale of a single treatment site. Thus, this analysis provides routine data on patient´s characteristics, treatment modalities and outcome in a single first level hospital in RLP during the first three Covid-19 surges during 03/2020 – 07/2021.","PeriodicalId":246370,"journal":{"name":"Thrombosis & Haemostasis: Research","volume":"56 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-07-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Thrombosis & Haemostasis: Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.26420/thrombhaemostres.2022.1076","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

The worldwide spread of SARS-CoV-2 profoundly affected almost all aspects of public life and challenged international and national health institutions of all different medical care levels including Europe up from the very beginning in 2020 until today. Public and press perception might have been weighed somehow towards third level health care providers offering treatment options like ECMO therapy for Covid-19 patients with the worst disease course, the majority of patients who needed hospital care were treated in hospitals of the first level. These hospitals provided about 50% of intensive care treatments in the federal state of Rhineland Palatinate (RLP) in Germany, too [1]. According to the Destatis [2] about 71000 additional deaths were registered in Germany during the first 12 months (02/2020 – 02/2021) of pandemic of which about 50000 could be attributed to Covid-19 as given in the medical death reports. However, only few data has been published on the concrete disease course and patient´s outcome on the scale of a single treatment site. Thus, this analysis provides routine data on patient´s characteristics, treatment modalities and outcome in a single first level hospital in RLP during the first three Covid-19 surges during 03/2020 – 07/2021.
2020年3月至2021年7月前三次新冠肺炎疫情暴发期间西德某地区一级医院病程及患者特征分析
从2020年开始到今天,SARS-CoV-2在全球范围内的传播深刻影响了公共生活的几乎所有方面,并对包括欧洲在内的所有不同医疗水平的国际和国家卫生机构提出了挑战。公众和媒体的看法可能在某种程度上倾向于三级医疗保健提供者,为病程最严重的Covid-19患者提供ECMO治疗等治疗选择,大多数需要住院治疗的患者在一级医院接受治疗。这些医院也提供了德国联邦莱茵兰-普法尔茨州(RLP)约50%的重症监护治疗[1]。根据Destatis[2]的数据,在大流行的前12个月(2020年2月至2021年2月),德国登记的新增死亡人数约为71000人,其中约50000人可归因于医疗死亡报告中的Covid-19。然而,在单个治疗点的规模上,关于具体病程和患者结果的数据很少。因此,该分析提供了2020年3月至2021年7月前三次Covid-19激增期间RLP一家一级医院患者特征、治疗方式和结果的常规数据。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信